Scienture Holdings Inc (SCNX)

전일 마감가:

$7.32

열려 있는:

$6.8992

하루 거래량:

10,872

Relative Volume:

18.05

시가총액:

$13.06M

수익:

-

순이익/손실:

-

주가수익비율:

-

EPS:

-

순현금흐름:

-

1주 성능:

+0.00%

1개월 성능:

+0.00%

6개월 성능:

+0.00%

1년 성능:

+0.00%

1일 변동 폭

$6.8992

$7.46

1주일 범위:

$6.8992

$7.6411

52주 변동 폭

$6.8992

$7.6411

Scienture Holdings Inc Stock (SCNX) Company Profile

명칭

Scienture Holdings Inc

부문

Healthcare (1190)

산업

Pharmaceutical Retailers (9)

전화

(800) 261 0281

주소

2420 BRUNELLO TRACE, LUTZ

직원

8

트위터

다음 수익 날짜

최신 SEC 제출 서류

SCNX's Discussions on Twitter

Scienture Holdings Inc 주식(SCNX)의 최신 뉴스

Sep 24, 2024

Scienture Holdings Unveils New Identity Post-Merger - TipRanks

Sep 24, 2024

Sep 24, 2024

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

Sep 24, 2024

Sep 24, 2024

SCNXScienture Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 24, 2024

Sep 20, 2024

Trxade Health announces name change to Scienture Holdings - TipRanks

Sep 20, 2024

Sep 20, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - StockTitan

Sep 20, 2024

Jul 29, 2024

TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers

Jul 29, 2024

Jul 26, 2024

$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com

Jul 26, 2024

Jun 27, 2024

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan

Jun 27, 2024

Jun 25, 2024

Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet

Jun 25, 2024

Jun 06, 2024

Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet

Jun 06, 2024

Apr 04, 2024

Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet

Apr 04, 2024

Dec 10, 2023

Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance

Dec 10, 2023

Sep 04, 2023

symbol__ Stock Quote Price and Forecast - CNN

Sep 04, 2023

Apr 11, 2023

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet

Apr 11, 2023

May 23, 2022

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet

May 23, 2022

Jul 29, 2020

No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet

Jul 29, 2020

Feb 17, 2020

MEDS Stock Price and Chart — NASDAQ:MEDS - TradingView

Feb 17, 2020

Dec 23, 2014

Trxade Group, Inc. Elects Donald Almeida to Board of Directors - Marketscreener.com

Dec 23, 2014

Scienture Holdings Inc (SCNX) 재무 분석

매출

순이익

현금흐름

주당 순 이익